ADC Therapeutics SA
ADCT
$3.70
-$0.26-6.57%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -142.62M | -166.94M | -169.94M | -149.84M | -157.85M |
| Total Depreciation and Amortization | 1.88M | 2.56M | 3.24M | 3.23M | 3.28M |
| Total Amortization of Deferred Charges | 1.82M | 1.02M | 800.00K | 590.00K | 902.00K |
| Total Other Non-Cash Items | 23.11M | 35.21M | 34.19M | 25.71M | 26.01M |
| Change in Net Operating Assets | -25.36M | -3.75M | 4.40M | -15.77M | 3.83M |
| Cash from Operations | -141.17M | -131.90M | -127.32M | -136.07M | -123.84M |
| Capital Expenditure | -264.00K | -354.00K | -570.00K | -600.00K | -867.00K |
| Sale of Property, Plant, and Equipment | 659.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 395.00K | -354.00K | -570.00K | -600.00K | -867.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 152.66M | 94.35M | 94.35M | 99.01M | 99.10M |
| Repurchase of Common Stock | -1.71M | -1.61M | -2.29M | -2.04M | -2.04M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 150.95M | 92.74M | 92.06M | 96.97M | 97.05M |
| Foreign Exchange rate Adjustments | 305.00K | -13.00K | 272.00K | 121.00K | -83.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.47M | -39.53M | -35.56M | -39.58M | -27.73M |